Not Medicare Enrolled

Dr. Virginia Araiza, M.D.

Pediatric Endocrinology · Houston, TX
3701 W ALABAMA ST STE 350, Houston, TX 77027
7135723200
Registered in NPPES since 2009
NPI: 1164757712 verify on NPPES ↗
Moderate
DATA COVERAGE
Data in 2 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Araiza from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Araiza? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Araiza

Dr. Virginia Araiza is a pediatric endocrinology specialist in Houston, TX, with 16 years of NPI registration.

Between the years covered by Open Payments, Dr. Araiza received a total of $252,331 from 33 pharmaceutical and/or device companies across 693 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Araiza is Moderate — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 16 years of NPI registration $252,331 industry payments

Industry Payment Transparency

Open Payments through 2024 ↗
$252,331
Total received (2018-2024)
Avg $36,047/year across 7 years
Top 0% in TX for pediatric endocrinology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
693
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →

Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$40,158
2023
$5,588
2022
$9,594
2021
$8,902
2020
$15,688
2019
$55,910
2018
$116,492

Payments by company (2024)

Alexion Pharmaceuticals, Inc.
$39,345
ABBVIE INC.
$147
Abbott Laboratories
$100
Insulet Corporation
$66
Ascendis Pharma Inc
$66
Amphastar Pharmaceuticals, Inc.
$57
Novo Nordisk Inc
$50
Tandem Diabetes Care, Inc.
$49
Azurity Pharmaceuticals, Inc.
$49
SANOFI-AVENTIS U.S. LLC
$44
Neurocrine Biosciences, Inc.
$40
Xeris Pharmaceuticals, Inc.
$26
Tolmar, Inc.
$25
Eton Pharmaceuticals, Inc.
$22
Dexcom, Inc.
$21
IBSA Pharma Inc.
$20
BETA BIONICS, INC.
$16
Kyowa Kirin, Inc.
$15
Top 3 companies account for 98.6% of 2024 payments
All-time payments by company (2018-2024) ›
Alexion Pharmaceuticals, Inc.
$247,489
Novo Nordisk Inc
$618
AbbVie Inc.
$572
Abbott Laboratories
$510
Insulet Corporation
$398
AbbVie, Inc.
$385
ABBVIE INC.
$293
Tandem Diabetes Care, Inc.
$219
Dexcom, Inc.
$197
Xeris Pharmaceuticals, Inc.
$186
SANOFI-AVENTIS U.S. LLC
$148
Tris Pharma Inc
$124
Ferring Pharmaceuticals Inc.
$124
CeQur Corporation
$112
IBSA Pharma Inc.
$95
Ascendis Pharma Inc
$93
Zealand Pharma US, Inc.
$85
PFIZER INC.
$83
Companion Medical, Inc.
$77
Eton Pharmaceuticals, Inc.
$73
DEXCOM, INC.
$64
Amphastar Pharmaceuticals, Inc.
$57
Amneal Pharmaceuticals LLC
$54
Azurity Pharmaceuticals, Inc.
$49
Neurocrine Biosciences, Inc.
$40
Cranial Technologies, Inc
$37
ARBOR PHARMACEUTICALS, INC.
$29
Lilly USA, LLC
$26
Tolmar, Inc.
$25
Ascendis Pharma, Inc.
$23
BETA BIONICS, INC.
$16
Kyowa Kirin, Inc.
$15
Ultragenyx Pharmaceutical Inc.
$14
Top 3 companies account for 98.6% of all-time payments
Associated products mentioned in payments ›
ALKINDI · BAQSIMI · CeQur Simplicity · Crysvita · DEXCOM CGM · DEXCOM G6 CGM SYSTEM · DEXCOM G6 TRANSMITTER · Dexcom G6 Transmitter · Doc Band · Dyanavel XR · FENSOLVI · FREESTYLE LIBRE · FreeStyle Libre · GENOTROPIN · GVOKE HYPOPEN · GVOKE PFS · InPen · LUPRON DEPOT · Lupron · Lupron Depot · Norditropin · Omnipod · SKYTROFA · SOLIRIS · STRENSIQ · SYNTHROID · Skytrofa · Sogroya · Strensiq · TOUJEO · TRIPTODUR · TZIELD · Tirosint · Triptodur · UNITHROID · V-GO DISPOSABLE INSULIN DELIVERY · Victoza · ZEGALOGUE · ZOMACTON · iLet Bionic Pancreas · t-slim insulin pump · t:slim X2 Insulin Pump with Control-IQ · t:slim X2 insulin pump
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Looking for a pediatric endocrinology specialist in Houston?
Compare pediatric endocrinologists in the Houston area by procedure volume, costs, and industry payment transparency.
Browse pediatric endocrinologists nearby

Geographic Context

Pediatric endocrinologists in nearby ZIP areas
41
County median income
$73,104
Nearest hospital to ZIP centroid (approximate)
BEHAVIORAL HOSPITAL OF BELLAIRE
2.7 mi

Data Sources

Provider Registry ✓ NPPES NPPES snapshot; verify current record
Medicare Enrollment — Not enrolled N/A
Practice Data — No data N/A
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not included N/A

This provider has data in 2 of 4 available federal datasets, with a Data Coverage level of Moderate. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Araiza is a pediatric endocrinology specialist, with 16 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Does Dr. Araiza receive payments from pharmaceutical companies?
Yes. Dr. Araiza received a total of $252,331 from 33 companies across 693 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
What does Data Coverage mean?
Data Coverage (currently Moderate for Dr. Araiza) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →

Explore related providers

Same specialty & city
Pediatric Endocrinologists in Houston
Browse pediatric endocrinologists in Houston ranked by procedure volume and transparency data.
Highest volume
Top Pediatric Endocrinologists in TX
Pediatric endocrinologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Pediatric Endocrinologists in TX
Which TX pediatric endocrinologists receive the most from drug and device companies.
By company
Alexion Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Alexion Pharmaceuticals, Inc.
By company
Novo Nordisk Inc Payments to Doctors
See all physicians who received payments from Novo Nordisk Inc.
By company
AbbVie Inc. Payments to Doctors
See all physicians who received payments from AbbVie Inc.
About this page

This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Industry payment disclosure alone establishes neither wrongdoing nor legality. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →